Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01262300 · ClinicalTrials.gov registry record · Phase 1
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT01262300 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 33 participants.
The verdict
NCT01262300, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is an ancillary study to a randomized controlled trial of high dose vitamin D in older long-term care residents (NCT01102374). In this study, a subset of trial subjects will receive the zoster vaccine and the investigators will determine the immunological response to the vaccine in this older, frail population, as well as the association between vitamin D and immunological outcomes.
Interventions
- BIOLOGICAL Varicella Zoster Virus Vaccine (Zostavax)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-01-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01262300
The ClinicalTrials.gov registry entry for NCT01262300 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varicella Zoster Virus Vaccine (Zostavax) is the first listed.
NCT01262300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01262300 about?
NCT01262300 is a clinical study titled "Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents". This is an ancillary study to a randomized controlled trial of high dose vitamin D in older long-term care residents (NCT01102374). In this study, a subset of trial subjects will receive the zoster vaccine and the investigators will determine the immunological response to the vaccine in this older, ...
What is the current status of trial NCT01262300?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2010-11. Estimated completion is 2014-01-23.
What interventions are being tested in trial NCT01262300?
The interventions under investigation include: Varicella Zoster Virus Vaccine (Zostavax) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01262300?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.